SCOTUS Must Not Look Away as Pregnant Patients Suffer
The Supreme Court must maintain pregnant people’s right to receive emergency medical care—including abortion.
A New Era of Psychedelic Medicine in Australia
Australia implements a new framework for regulating the medicinal use of psychedelic substances such as MDMA and psilocybin.
It Is High Time the U.K. Changes Psychedelics Laws
The government should lower regulatory hurdles impeding psilocybin assisted psychotherapy research.
Why We Need To Talk About Psychedelic Dispensaries
Dispensaries could fill the regulatory void for psychedelics and promote public health.
Are Psychedelics Safe Enough for Recreational Use?
Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.
A Roadmap to Reimbursement for Psychedelics
Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.
Branching Regulatory Paths and Dead Ends in Psychedelics
The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.
AI Providers Should Not Be Liable for Users’ Securities Violations
Policymakers are considering a liability regime that is bad economics and bad law.
What Do U.S. Courts Say About the Use of AI?
An analysis of state and federal court decisions uncovers standards to guide governmental use of artificial intelligence.
A Global Administrative Law for an Era of AI
Policymakers should follow three steps when regulating artificial intelligence on a global scale.
The Supreme Court’s Self-Coronation
The U.S. Supreme Court’s current docket presents the Court with more opportunities to empower itself at the expense of other governmental institutions.
Safety Culture vs. Safety Systems in U.S. Transportation
Regulators should focus on forging a safety culture to reduce automotive accidents and fatalities.